Compare PAGSEG Inc (PAGS) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
PAGSEG Inc vs BIO-TECHNE Corp — how do they compare? PAGSEG Inc trades at $9.69 (market cap $2.68B), while BIO-TECHNE Corp trades at $71.73 (market cap $11.16B). The key difference: BIO-TECHNE Corp is far larger — about 4.2× PAGSEG Inc's market cap, and PAGSEG Inc pays the higher dividend (10.86%). Which is the better fit depends on your goals.
| PAGS | TECH | |
|---|---|---|
Market Cap | $2.68B | $11.16B |
Sector | Technology | Health |
52-Week High | $12.00 | $72.12 |
52-Week Low | $7.75 | $43.31 |
Enterprise Value | $10.42B | $11.24B |
Dividend Yield | 10.86% | 0.45% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
PAGS trades at $9.29, up 2.77% with a bullish technical signal. The stock shows attractive valuation metrics with P/E of 6.57 and P/S of 0.68, trading below book value. Recent earnings showed mixed results with Q4 2025 beating expectations but Q1 2026 missing estimates. The company maintains strong profitability with 10.4% net margin and robust cash flow generation of $7.56B from operations in 2025.
Analyst consensus remains strongly bullish with 62.5% buy ratings, though Brazilian macroeconomic risks and competitive pressures warrant monitoring. The stock presents value opportunity with deep discount valuation while benefiting from Brazil's digital banking growth, though execution on credit expansion and funding costs remain key catalysts.
Bio-Techne (TECH) trades at $71.63, down 0.68% on the day, near its all-time high following a $73 per share acquisition offer from Merck KGaA. The stock shows bullish technical signals with strong moving averages and ADX trends. Fundamentally, the company reported mixed quarterly earnings but maintains solid gross margins of 64.96%. Recent news is dominated by the proposed $11.3 billion buyout, driving significant investor interest and legal scrutiny over the transaction's fairness.
The outlook is heavily influenced by the pending acquisition, with upside capped near the $73 offer price. Risks include shareholder litigation and regulatory approval delays. Analyst consensus is split evenly between Buy and Hold, reflecting uncertainty around deal completion. The stock presents a potential arbitrage opportunity if the acquisition proceeds, but carries event risk if the transaction fails.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About PAGSEG Inc
PagSeguro Digital Ltd. is a leading provider of financial technology solutions in Brazil, primarily focused on e-commerce, face-to-face transactions, and financial services. The company's main offerings include PagBank, a digital banking platform, and PagSeguro, a suite of payment processing solutions that includes point-of-sale devices and online payment gateways. PAGS targets micro-merchants, small and medium-sized enterprises (SMEs), and consumers, aiming to democratize access to financial services in the country.
Read more on PAGS →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
